Compare VBF & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VBF | AMRN |
|---|---|---|
| Founded | N/A | 1989 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 172.1M | 339.8M |
| IPO Year | 1995 | 1998 |
| Metric | VBF | AMRN |
|---|---|---|
| Price | $14.78 | $14.45 |
| Analyst Decision | | Strong Sell |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | ★ 73.2K | 61.8K |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 55.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $181,104,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.26 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 39.22 |
| 52 Week Low | $14.33 | $0.39 |
| 52 Week High | $15.98 | $20.90 |
| Indicator | VBF | AMRN |
|---|---|---|
| Relative Strength Index (RSI) | 26.61 | 43.34 |
| Support Level | N/A | $13.63 |
| Resistance Level | $15.62 | $14.55 |
| Average True Range (ATR) | 0.13 | 0.72 |
| MACD | -0.02 | -0.08 |
| Stochastic Oscillator | 23.64 | 6.51 |
Invesco Bond Fund is an independent investment management firm. Its investment objective is to seek interest income while conserving capital.
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.